These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 39421223)
1. A Rare Case of Systemic Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis in an Immunocompetent Young Man: Potential Diagnostic Pitfall and Therapeutic Challenge. Liu SY; Zhao S; Wu Y; He GC J Med Cases; 2024 Nov; 15(11):347-353. PubMed ID: 39421223 [TBL] [Abstract][Full Text] [Related]
2. Successful treatment of refractory retroperitoneal Epstein-Barr virus-positive diffuse large B-cell lymphoma with secondary hemophagocytic syndrome by sequential combination regimen of PD-1 blockade and chimeric antigen receptor T cells: a case report. Yu M; Zhang Q; Xu S; Yin T; Li F Anticancer Drugs; 2022 Jan; 33(1):e769-e775. PubMed ID: 34387604 [TBL] [Abstract][Full Text] [Related]
3. Differentiating fulminant EBV infection complicated by HLH from Lymphoma: report of a case and a brief literature review. Zehr B; Brannock K; Wyma R; Kahwash SB Diagn Pathol; 2023 Feb; 18(1):28. PubMed ID: 36814281 [TBL] [Abstract][Full Text] [Related]
4. A rare case of diffuse large B-cell lymphoma-associated hemophagocytic lymphohistiocytosis. Malkan UY; Albayrak M; Yildiz A; Maral S; Afacan Ozturk HB; Comert P J Oncol Pharm Pract; 2021 Jan; 27(1):250-252. PubMed ID: 32507098 [TBL] [Abstract][Full Text] [Related]
5. Hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus-positive diffuse large B-cell lymphoma, NOS of bone marrow-liver-spleen type: an autopsy case report. Iizuka H; Mori Y; Iwao N; Koike M; Noguchi M J Clin Exp Hematop; 2021 Jun; 61(2):102-108. PubMed ID: 33994430 [TBL] [Abstract][Full Text] [Related]
6. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature. Yang QX; Pei XJ; Tian XY; Li Y; Li Z Diagn Pathol; 2012 Jan; 7():7. PubMed ID: 22260632 [TBL] [Abstract][Full Text] [Related]
7. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma. Skugor ND; Perić Z; Vrhovac R; Radić-Kristo D; Kardum-Skelin I; Jaksić B Coll Antropol; 2010 Mar; 34(1):241-5. PubMed ID: 20432757 [TBL] [Abstract][Full Text] [Related]
8. Epstein Virus Barr-Positive Diffuse Large B-Cell Lymphoma Associated with Hemophagocytic Lymphohistiocytosis. Ricard JA; Charles R; Tommee CG; Yohe S; Bell WR; Flanagan ME J Neuropathol Exp Neurol; 2020 Aug; 79(8):915-920. PubMed ID: 32647871 [TBL] [Abstract][Full Text] [Related]
9. Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma. Beltran BE; Quiñones P; Morales D; Malaga JM; Chavez JC; Sotomayor EM; Castillo JJ Hematol Oncol; 2018 Feb; 36(1):93-97. PubMed ID: 28639256 [TBL] [Abstract][Full Text] [Related]
10. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease]. Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280 [No Abstract] [Full Text] [Related]
11. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey. Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928 [TBL] [Abstract][Full Text] [Related]
12. Chronic active Epstein-Barr virus infection of T-cell type, systemic form in an African migrant: case report and review of the literature on diagnostics standards and therapeutic options. Wass M; Bauer M; Pfannes R; Lorenz K; Odparlik A; Müller LP; Wickenhauser C BMC Cancer; 2018 Oct; 18(1):941. PubMed ID: 30285657 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr Virus-Positive Adrenal Diffuse Large B-Cell Lymphoma after Treatment for Angioimmunoblastic T-Cell Lymphoma. Hashimoto A; Asai S; Tanaka Y; Shinzato I Eur J Case Rep Intern Med; 2021; 8(10):002533. PubMed ID: 34790617 [TBL] [Abstract][Full Text] [Related]
14. A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis. Yoon SE; Kim SJ; Yoon DH; Koh Y; Mun YC; Do YR; Choi YS; Yang DH; Kim MK; Lee GW; Suh C; Ko YH; Kim WS Ann Hematol; 2020 Jun; 99(6):1283-1291. PubMed ID: 32333154 [TBL] [Abstract][Full Text] [Related]
15. Secondary Hemophagocytic Lymphohistiocytosis With Epstein-Barr Virus-Associated Transformed Follicular Lymphoma: A Case Report and Literature Review. Xu H; Xu X; Cui G; Fang J; Chen W; Xue M; Jin R; Chen H; Zhang L; Hu Y Front Oncol; 2021; 11():681432. PubMed ID: 34249725 [TBL] [Abstract][Full Text] [Related]
16. T-cell lymphoma with a granulomatous lesion of the lungs after autologous hematopoietic stem cell transplantation for Epstein-Barr virus-positive diffuse large B-cell lymphoma: a unique rare case of metachronous B-cell and T-cell lymphoma. Kajimoto Y; Terasaki Y; Terasaki M; Kunugi S; Okabe Y; Wakita S; Inokuchi K; Shimizu A Diagn Pathol; 2020 Oct; 15(1):125. PubMed ID: 33036636 [TBL] [Abstract][Full Text] [Related]
17. Successful Treatment of Relapsed Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis After Allo-HSCT with PD-1 Blockade: A Case Report. Pi Y; Wang J; Wang Z Infect Drug Resist; 2022; 15():3751-3756. PubMed ID: 35859915 [TBL] [Abstract][Full Text] [Related]
18. Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis. Koizumi Y; Imadome KI; Ota Y; Minamiguchi H; Kodama Y; Watanabe D; Mikamo H; Uehira T; Okada S; Shirasaka T J Clin Immunol; 2018 May; 38(4):478-483. PubMed ID: 29687211 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era. Sato A; Nakamura N; Kojima M; Ohmachi K; Carreras J; Kikuti YY; Numata H; Ohgiya D; Tazume K; Amaki J; Moriuchi M; Miyamoto M; Aoyama Y; Kawai H; Ichiki A; Hara R; Kawada H; Ogawa Y; Ando K Cancer Sci; 2014 Sep; 105(9):1170-5. PubMed ID: 24974976 [TBL] [Abstract][Full Text] [Related]